All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • include docetaxelPhase 31 trial

    Shanghai Runshi Pharmaceutical Technology Co., Ltd · Advanced Oesophageal Squamous Cell Carcinoma

  • INS068Phase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Type 2 Diabetes

  • INT230-6Phase 31 trial

    Intensity Therapeutics, Inc. · Sarcoma,Soft Tissue

  • Roche (Genentech) · Diabetic Macular Edema

  • ION363Phase 31 trial

    Ionis Pharmaceuticals · Amyotrophic Lateral Sclerosis

  • Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • IPN60340Phase 31 trial

    Ipsen · Acute Myeloid Leukaemia (AML), Acute Myeloid Leukaemia

  • IptilimumabPhase 31 trial

    InSightec · Brain Tumor, Non Small Cell Lung Cancer

  • IS-001Phase 31 trial

    Intuitive Surgical · Ureter Injury

  • IVA337LanifibranorPhase 31 trial

    Inventiva Pharma · NASH - Nonalcoholic Steatohepatitis

  • JKN2401Phase 31 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · Chronic Obstructive Pulmonary Disease (COPD)

  • JMKX001899Phase 31 trial

    Jemincare · NSCLC (Non-small Cell Lung Cancer)

  • JNJ-87189401Phase 31 trial

    Johnson & Johnson (Janssen) · Metastatic Castration-resistant Prostatic Neoplasms

  • JW0104Phase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • JW0108Phase 31 trial

    JW Pharmaceutical · Dyslipidemia

  • JX10Phase 31 trial

    Corxel Pharmaceuticals · Acute Ischemic Stroke

  • JYP0035Phase 31 trial

    Chengdu JOYO pharma Co., Ltd. · Breast Cancer

  • JZP926Phase 31 trial

    Jazz Pharmaceuticals · Juvenile Myoclonic Epilepsy

  • KB803Phase 31 trial

    Krystal Biotech, Inc. · Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa

  • KK8398Phase 31 trial

    Kyowa Kirin Co., Ltd. · Achondroplasia

  • KP-001Phase 31 trial

    Kaken Pharmaceutical · Venous Malformations, Lymphatic Malformations, Klippel-Trenaunay Syndrome

  • KP-100ITPhase 31 trial

    Kringle Pharma, Inc. · Acute Spinal Cord Injury (SCI)

  • KP-100LIHepatocyte Growth Factor, HGFPhase 31 trial

    Kringle Pharma, Inc. · Vocal Fold Scar

  • KPS-0373Phase 31 trial

    Kissei Pharmaceutical Co., Ltd. · Spinocerebellar Degeneration

  • L606Treprostinil LiposomePhase 31 trial

    Liquidia Technologies, Inc. · Pulmonary Hypertension Due to Lung Disease (Disorder)

  • Larazotide AcetatePhase 31 trial

    Interlude Biopharma Co. · Celiac Disease, Celiac Disease in Adolescents

  • LerotinibZ650Phase 31 trial

    Sunshine Lake Pharma Co., Ltd. · Esophageal Cancer

  • LevilimabPhase 31 trial

    Biocad · Rheumatoid Arthritis

  • LibevitugPhase 31 trial

    Huahui Health · Chronic Hepatitis D Infection

  • licaminlimabPhase 31 trial

    Oculis · Dry Eye Disease (DED)

  • LID104Phase 31 trial

    EMS · Type 2 Diabetes Mellitus

  • LMN-201Phase 31 trial

    Lumen Bioscience, Inc. · Clostridioides Difficile Infection

  • LNS8801Phase 31 trial

    Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • LW402Phase 31 trial

    Shanghai Longwood Biopharmaceuticals Co., Ltd. · Moderate to Severe Atopic Dermatitis

  • LY01015Phase 31 trial

    Shandong Boan Biotechnology Co., Ltd · Esophageal Squamous Cell Carcinoma

  • LYB005Phase 31 trial

    Guangzhou Patronus Biotech Co., Ltd. · Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine

  • LYR-210Phase 31 trial

    Lyra Therapeutics · Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)

  • LZM012Phase 31 trial

    Livzon Pharmaceutical Group Inc. · Psoriasis

  • M701Phase 31 trial

    Wuhan YZY Biopharma Co., Ltd. · Malignant Ascites

  • Novo Nordisk · Overweight, Obesity, Type 2 Diabetes

  • Alpine Immune Sciences Inc, A Subsidiary of Vertex · Immunoglobulin A Nephropathy

  • MB11Proposed Nivolumab BiosimilarPhase 31 trial

    mAbxience Research S.L. · Advanced (Unresectable or Metastatic) Melanoma

  • MB12Proposed Pembrolizumab BiosimilarPhase 31 trial

    mAbxience Research S.L. · Non Squamous Non Small Cell Lung Cancer

  • MDR-001Phase 31 trial

    MindRank AI Ltd · Overweight or Obesity

  • MLC 901Phase 31 trial

    Moleac Pte Ltd. · Alzheimer's Disease Dementia

  • MN-166ibudilastPhase 31 trial

    MediciNova · Amyotrophic Lateral Sclerosis

  • MolnupiravirMK-4482, LAGEVRIOPhase 31 trial

    Merck & Co. · Coronavirus Disease (COVID-19)

  • MR-100A-01Transdermal contraceptive delivery systemPhase 31 trial

    Mylan Technologies Inc. · Contraception

  • MR-107A-02Phase 31 trial

    Viatris Specialty LLC · Acute Pain, Post Operative Pain, Pain

  • MRG002Phase 31 trial

    Shanghai Miracogen Inc. · Advanced or Metastatic Urothelium Cancer

NewerPage 25 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.